In the first full week of April 2020, the worldwide healthcare community has marked World Health Day by acknowledging the work of nurses and midwives, particularly the key role they are playing particularly within the current COVID-19 outbreak. We also bring you news related to key efforts in tackling COVID-19 from the FDA, and the potential for using CRISPR as a diagnostic technology. Outside of COVID-19 related news we also cover the reported decline in c.diff infections across the USA, new insights into the brain to help Alzheimer’s research, diabetes prevention efforts, and biologics for the treatment of psoriasis.
World Health Day Recognizes Nurses and Midwives
On April 7 the World Health Organization marked World Health Day by celebrating the work of nurses and midwives. Using this platform to remind world leaders of the critical role they play in keeping the world healthy. Nurses and other health workers are at the forefront of COVID-19 response - providing high quality, respectful treatment and care.
Decline in C.diff Cases Correlates with Decrease in Healthcare-Associated Cases
The estimated national burden of Clostridioides difficile infections and related hospitalizations declined between 2011 and 2017 because of a decrease in health care-associated infections, according to findings published in the New England Journal of Medicine.
A Point-of-Care CRISPR-Based COVID-19 Diagnostic Could Be on the Horizon
As part of ongoing efforts to try to reduce the spread of COVID-19, researchers around the world are working hard to develop novel diagnostic technologies. Rapid and simple identification of people infected with SARS-CoV-2 plays a crucial role in reducing transmission of the virus, by enabling appropriate isolation measures and contact tracing to take place.
New understanding of Brain Structure Offers Insights into Alzheimer's
A new study has revealed more detail about key brain cells. The team of investigators has found that a structure in the brain is arranged differently than the scientific community once believed. The discovery may have implications for the understanding of neurodegenerative illnesses such as Alzheimer’s disease.
Which Biologics Provide the Greatest Improvement in Psoriasis?
Patients with moderate-to-severe psoriasis, that is, where more than 10% of their body surface area is affected, are normally managed with a group of monoclonal antibody drugs (biologics). These drugs have revolutionized the management of patients with moderate-to-severe psoriasis but how do clinicians decide which treatment to use? A recent study has shed light on this important question.
Preventing Type 1 Diabetes by Deleting a Stress Response Gene
In Type 1 diabetes, the immune system’s T cells mistakenly attack insulin-producing beta cells. Physicians can identify many patients who are at risk for developing the disease using blood tests to identify abnormal autoantibodies, but there’s nothing they can do to actually prevent the disease.
FDA Coordinates Effort to Develop Blood-Related Therapies for COVID-19
The U.S. Food and Drug Administration continues to play a critical role in accelerating medical countermeasures to treat and prevent COVID-19. As part of the response to this pandemic, the agency is taking the lead on a national effort to facilitate the development of, and access to, two investigational therapies derived from human blood.